The Power of Modern Public Health in Practice. A Georgian Case Commentary on Risk Communication, Digital Health Ecosystems, and Regulatory Action During the Global Nestlé Infant Formula Recall (January 2026)

Abstract In January 2026, Nestlé initiated a voluntary recall of selected infant and follow-on formula products following identification of a potential safety concern related to cereulide, a heat-stable emetic toxin produced by some strains of Bacillus cereus, associated in public reporting with a quality issue in an upstream ingredient (arachidonic acid oil, ARA) supplied by a third party [1–3]. Within days, recall actions and official warnings expanded across continents. By 9 January 2026, international media and food-safety reporting indicated that more than 50 countries and market jurisdictions had issued recalls or public warnings [2–4]. Despite this escalation, Georgia was not listed on Nestlé’s official global advisory webpage as accessed on 8–9 January 2026, which explicitly states that its list of affected countries is “not exhaustive” [5]. Nevertheless, on 8 January 2026 the National Food Agency of Georgia publicly confirmed the supervised withdrawal of specific infant formula batches from the Georgian market and issued consumer warnings, disseminated by national broadcasters and news agencies [6–8]. This commentary presents the Georgian response as a case study demonstrating how modern public health—through evidence synthesis, rapid translation, independent digital health platforms, algorithm-aware dissemination, and institutional engagement—can shorten time-to-protection in the context of multinational corporate information asymmetry.